Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 3547.00 | 3812.75 | 0.9303 | 0.9001 |
| BT-20 | Erlotinib | 10 | uM | 7 | 312.50 | 133.67 | 235.00 | 277.50 | 0.8469 | 0.7081 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 312.50 | 133.67 | 532.00 | 277.50 | 1.9171 | 2.7088 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 1643.00 | 1780.00 | 0.9230 | 0.8872 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 2137.00 | 1780.00 | 1.2006 | 1.2834 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 312.50 | 133.67 | 328.00 | 277.50 | 1.1820 | 1.3439 |
| BT-20 | Erlotinib | 10 | uM | 9 | 1250.00 | 684.27 | 1104.00 | 1780.00 | 0.6202 | 0.4146 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1409.00 | 1780.00 | 0.7916 | 0.6882 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 1738.00 | 1780.00 | 0.9764 | 0.9657 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 625.00 | 320.09 | 833.00 | 817.25 | 1.0193 | 1.0284 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 684.27 | 946.00 | 1780.00 | 0.5315 | 0.2647 |
| MCF 10A | Erlotinib | 0.031623 | uM | 7 | 5000.00 | 370.81 | 10358.00 | 10735.50 | 0.9648 | 0.9853 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 312.50 | 133.67 | 287.00 | 277.50 | 1.0342 | 1.0649 |
| MCF 10A | Erlotinib | 3.1623 | uM | 7 | 156.25 | 15.92 | 62.00 | 133.50 | 0.4644 | 0.5577 |
| MCF 10A | Erlotinib | 19.9526 | uM | 7 | 5000.00 | 370.81 | 3999.00 | 10735.50 | 0.3725 | 0.6319 |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 1250.00 | 580.08 | 1904.00 | 1814.50 | 1.0493 | 1.0594 |
| MCF 10A | Erlotinib | 0.1 | uM | 7 | 5000.00 | 370.81 | 9876.00 | 10735.50 | 0.9199 | 0.9659 |
| BT-20 | Erlotinib | 1 | uM | 9 | 1250.00 | 684.27 | 1495.00 | 1780.00 | 0.8399 | 0.7623 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 2919.00 | 3812.75 | 0.7656 | 0.6548 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 625.00 | 320.09 | 700.00 | 817.25 | 0.8565 | 0.7836 |
| BT-20 | Erlotinib | 10 | uM | 9 | 625.00 | 320.09 | 610.00 | 817.25 | 0.7464 | 0.6110 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 592.00 | 817.25 | 0.7244 | 0.5757 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 312.50 | 133.67 | 350.00 | 277.50 | 1.2613 | 1.4928 |
| BT-20 | Erlotinib | 1 | uM | 7 | 312.50 | 133.67 | 312.00 | 277.50 | 1.1243 | 1.2352 |
| BT-20 | Erlotinib | 1 | uM | 9 | 625.00 | 320.09 | 843.00 | 817.25 | 1.0315 | 1.0464 |